Pharmacovigilance Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Pharmacovigilance Market
Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0401
Updated Date: 16 May, 2018  

1. Pharmacovigilance Market – Overview
2. Executive Summary 
3. Pharmacovigilance Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Pharmacovigilance Market– Forces
   4.1. Drivers
      4.1.1. Strict drug regulations in developed nations
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Pharmacovigilance Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Pharmacovigilance Market, By Clinical Trial Phase
   6.1. Preclinical Studies
   6.2. Phase I/1
   6.3. Phase II/2
   6.4. Phase III/3
   6.5. Phase IV/4 Trial
7. Pharmacovigilance Market, By Type of Service Provider
   7.1. In House
   7.2. Contract Outsourcing
8. Pharmacovigilance Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America 
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Pharmacovigilance Market – Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Quintiles Transnational Corporation
   10.2. Accenture Plc.
   10.3. Boehringer Ingelheim GmbH
   10.4. Bristol-Myers Squibb
   10.5. PAREXEL International Corporation
   10.6. Janssen Research & Development, LLC
   10.7. Pharmaceutical Product Development, Inc.
   10.8. United BioSource Corporation
   10.9. Synowlwedge LLC
   10.10. Cognizant Technology Solutions Corporation
   10.11. Covance Inc. 
   10.12. ICON, Plc..
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll